Cerus Corp (CERS) stock

CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3022% below fair value

$1.94−0.18 (-8.49%)

Close on Nov 12, 2026Market cap $390.96MP/E –Yield –

Cerus profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Cerus's profit margin for the twelve months ending Sep 30, 2026 was -2.9%. For fiscal 2025 it was -6.7%, against -10.4% the year before. The highest annual figure on record is -6.7% in fiscal 2025.

Annual profit margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-6.7%	+3.7
FY2024	Dec 31, 2024	-10.4%	+9.7
FY2023	Dec 31, 2023	-20.1%	+2.6
FY2022	Dec 31, 2022	-22.7%	+11.4
FY2021	Dec 31, 2021	-34.1%	+18.3
FY2020	Dec 31, 2020	-52.4%	+23.6
FY2019	Dec 31, 2019	-76.0%	−0.3
FY2018	Dec 31, 2018	-75.7%	+42.3
FY2017	Dec 31, 2017	-118.0%	+42.1
FY2016	Dec 31, 2016	-160.2%	+3.1
FY2015	Dec 31, 2015	-163.2%	−56.8
FY2014	Dec 31, 2014	-106.4%	+2.9
FY2013	Dec 31, 2013	-109.3%	−66.0
FY2012	Dec 31, 2012	-43.3%	+8.1
FY2011	Dec 31, 2011	-51.4%	+21.8
FY2010	Dec 31, 2010	-73.2%	+61.0
FY2009	Dec 31, 2009	-134.2%	–

Quarterly profit margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	-1.0%	−0.9
Q2 FY2026	Jun 30, 2026	-5.1%	+5.8
Q1 FY2026	Mar 31, 2026	-3.1%	+14.8
Q4 FY2025	Dec 31, 2025	-2.6%	+48.6
Q3 FY2025	Sep 30, 2025	-0.0%	+92.1
Q2 FY2025	Jun 30, 2025	-10.9%	+75.3
Q1 FY2025	Mar 31, 2025	-17.8%	+84.5
Q4 FY2018	Dec 31, 2018	-51.2%	+19.6
Q3 FY2018	Sep 30, 2018	-92.2%	+32.1
Q2 FY2018	Jun 30, 2018	-86.1%	+93.2
Q1 FY2018	Mar 31, 2018	-102.4%	+163.1
Q4 FY2017	Dec 31, 2017	-70.7%	+62.6
Q3 FY2017	Sep 30, 2017	-124.3%	–
Q2 FY2017	Jun 30, 2017	-179.3%	–
Q1 FY2017	Mar 31, 2017	-265.5%	–
Q4 FY2016	Dec 31, 2016	-133.3%	–